Standardization of the red cell product

Transfusion and Apheresis Science

Volumn 34, Issue 2, 2006, Pages 213-218

  Sweeney, Joseph D ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APHERESIS; ARTICLE; BLOOD SAMPLING; BLOOD TRANSFUSION; BLOOD VOLUME; ERYTHROCYTE; GRAFT RECIPIENT; HUMAN; MEASUREMENT; MEDICAL PRACTICE; PHYSICIAN; PREDICTION; PRESCRIPTION; QUALITATIVE ANALYSIS; SCIENCE; STANDARD; TREATMENT OUTCOME;

BLOOD COMPONENT REMOVAL; BLOOD DONORS; BLOOD VOLUME; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HEMOGLOBINS; HUMANS;

EID: 33645981633     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2005.11.006     Document Type: Article

References (21)

1. Schmidt P.J. Transfusion in American in the eighteenth and nineteenth centuries. N Eng J Med 279 (1968) 1319-1320
2. Council of Europe. Guide to the preparation, use and quality assurance of blood components. 10th ed. (2004), Council of Europe Publishing, Strassbourg
3. Menitove J.E. Standards for blood banks and transfusion services. 22nd ed. (2003), American Association of Blood Banks, Bethesda (MD)
4. Klein H.G. Blood, drugs and the United States. Trans Med Rev 12 (1998) 81-83
5. Sweeney J.D. Universal leukoreduction of cellular blood components in 2001? Yes. Am J Clin Pathol 115 (2001) 666-673
6. Council of Europe Expert Committee in blood transfusion study group on pathogen inactivation of labile blood components. Pathogen inactivation of labile blood products. Trans Med 2001;11:149-75.
7. Kruskall M.S., AuBuchon J.P., Anthony K.Y., et al. Transfusion to blood group A and O patients of group B RBC's that have been enzymatically converted to group O. Transfusion 40 (2000) 1290-1298
8. Scott M.D., Bradley A.J., and Murad K.L. Camouflaged blood cells: technology bioengineering for transfusion medicine. Trans Med Rev 14 (2000) 53-63
9. Elizalde J.I., Clemente J., Marin L., et al. Early changes in hemoglobin and hematocrit levels after packed red cell transfusion in patients with acute anemia. Transfusion 37 (1997) 573-576
10. Arslan O., Toprak S., Arat M., and Kayalak Y. Hb content-based transfusion policy successfully reduces the number of RBC units transfused. Transfusion 44 (2004) 485-488
11. Ma M., Eckert K., Ralley F., and Chin-Yee I. A retrospective study evaluation single-unit red blood cell transfusions in reducing allogeneic blood exposure. Trans Med 15 (2005) 307-312
12. Regan F., Teesdale P., Garner S., et al. Comparison of in vivo red cell survival of donations collected by haemonetics MCS versus conventional collection. Trans Med 7 (1997) 25-28
13. Shi P.A., and Ness P.M. Two-unit red cell apheresis and its potential advantages over traditional whole-blood donation. Transfusion 39 (1999) 218-225
14. Matthes G.A. Options and cost effectiveness of multicomponent blood collection. Trans Apheresis Sci 27 (2002) 115-121
15. Popovsky M.A. Multicomponent apheresis blood collection in the United States: current status and future directions. Trans Apheresis Sci 32 (2005) 299-304
16. Hogman C.F., and Meryman H.T. Storage parameters affecting red blood cell survival and functions after transfusion. Trans Med Rev 13 (1999) 275-296
17. Tinmouth A., and Chin-Yee I. The clinical consequences of the red cell storage lesion. Trans Med Rev 15 (2001) 91-107
18. Arduino A., Holme S., Sweeney J.D., et al. Addition of l-carnitine to AS-3 suspended red cells stored at 4 °C reduces in vitro hemolysis and improves in vivo viability. Transfusion 37 (1997) 166-174
19. Hogman C.F., Knuttson F., Loof H., et al. Improved maintenance of 2,3DPG and ATP in RBC's stored in a modified additive solution. Transfusion 42 (2002) 824-829
20. Hess J.R., Rugg N., Gormas J.K., et al. RBC storage for 11 weeks. Transfusion 41 (2001) 1586-1590
21. Hess J.R., Hill H.R., Oliver C.K., et al. Alkaline CPD and the preservation of RBC 2,3DPG. Transfusion 42 (2002) 747-752